✦ LIBER ✦

A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma

✍ Scribed by Paul B. Chapman; Jonathan E. Kolitz; Thomas B. Hakes; Janice L. Gabrilove; Karl Welte; V. J. Merluzzi; Adelheid Engert; Edward C. Bradley; Michael Konrad; Roland Mertelsmann

Book ID: 118287224
Publisher: Springer US
Year: 1988
Tongue: English
Weight: 731 KB
Volume: 6
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00175395

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of intraperitoneal inte

A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer

✍ Anda M. Vlad; Raluca A. Budiu; Diana E. Lenzner; Yun Wang; Julia A. Thaller; Kel 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 375 KB

Intraperitoneal immunotherapy of human o

Intraperitoneal immunotherapy of human ovarian carcinoma with recombinant interferon: A phase I toxicity/immunopharmacology study

✍ J. Berek; N. Hacker; A. Lichtenstein; T. Jung; R. Knox; T. Greene; E. Bonnem; L. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Phase I trial of subcutaneous recombinan

Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma

✍ Omar Eton; Michael G. Rosenblum; Sewa S. Legha; Wehei Zhang; Mary Jo East; Agop 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

## Abstract ## BACKGROUND Interleukin‐2 (IL‐2) has activity in metastatic melanoma when given in high doses by the intravenous (IV) route, but its side effects and effectiveness when given in intermediate to high doses by the subcutaneous (SC) route have not been studied adequately. This study sou

A phase-II trial of recombinant interleu

A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma

✍ Hamblin, T.J.; Inzani, V.; Sadullah, S.; Stevenson, F.K.; Williamson, P.; van de 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Intraperitoneal therapy with interleukin

Intraperitoneal therapy with interleukin-2 (nIL-2) in patients with ovarian carcinoma — Pre-clinical and clinical results

✍ W Schröder; R Lissner; HC Bender 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Phase IB study of low-dose intraperitone

Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: Rationale and preliminary report

✍ U Beller; A Chachoua; JL Speyer; J Sorich; M Dugan; L Liebes; R Hayes; EM Beckma 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 266 KB